Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 30, 2026

Conditions
Sleep DisorderAging
Interventions
DIETARY_SUPPLEMENT

Fisetin intervention

Participants assigned to this intervention take capsules containing a fixed dose of Fisetin daily after breakfast.

DIETARY_SUPPLEMENT

Placebo

Participants assigned to this intervention take a capsule containing 500 mg of corn starch daily after breakfast.

DIETARY_SUPPLEMENT

Urolithin A intervention

Participants assigned to this intervention take capsules containing a fixed dose of Urolithin A daily after breakfast.

Trial Locations (1)

430000

Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Wuhan Wuchang Hospital

UNKNOWN

collaborator

Abinopharm, Inc

NETWORK

lead

Huazhong University of Science and Technology

OTHER

NCT06990256 - Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers | Biotech Hunter | Biotech Hunter